Literature DB >> 8557432

Sources of variability in prevalence rates of Alzheimer's disease.

M Corrada1, R Brookmeyer, C Kawas.   

Abstract

OBJECTIVE: To investigate potential methodological reasons for the differences in published Alzheimer's disease (AD) prevalence rates.
BACKGROUND: Studies reporting prevalence rates of AD have been published worldwide. These rates differ considerably, but may greatly reflect methodological differences.
METHODS: All studies published between 1984 and 1993 that reported age-specific AD rates and sample sizes were included. Logistic regression identified variables that contribute to the variation in rates. Estimates of extrabinomial variation were also calculated.
RESULTS: Studies characterized by the following features yielded significantly higher rates: inclusion of mild cases, use of laboratory studies, ascertainment of a sample rather than the total population, inclusion of both urban and rural populations, non-use of computerized tomography (CT) scans, non-use of the Hachinski Ischemic Score, and no adjustment for false negatives. The odds of having AD increased 18% for every year of age. The variation in the age-specific prevalence rates of AD was approximately 15 times that expected by sampling variation. However, approximately 76% of this excess variation in rates could be accounted for by methodological differences.
CONCLUSIONS: After accounting for age, much of the variability in prevalence rates of AD in the published literature may be explained by differences in methodology. Some unexplained variation in prevalence rates, however, still remains.

Entities:  

Mesh:

Year:  1995        PMID: 8557432     DOI: 10.1093/ije/24.5.1000

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  15 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

2.  Identification of dementia: agreement among national survey data, medicare claims, and death certificates.

Authors:  Truls Ostbye; Donald H Taylor; Elizabeth C Clipp; Lynn Van Scoyoc; Brenda L Plassman
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

3.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors:  R Brookmeyer; S Gray; C Kawas
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

4.  Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old.

Authors:  Ron Brookmeyer; Claudia H Kawas; Nada Abdallah; Annlia Paganini-Hill; Ronald C Kim; María M Corrada
Journal:  Alzheimers Dement       Date:  2016-02-17       Impact factor: 21.566

5.  Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States.

Authors:  Robert S Wilson; David R Weir; Sue E Leurgans; Denis A Evans; Liesi E Hebert; Kenneth M Langa; Brenda L Plassman; Brent J Small; David A Bennett
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

Review 6.  Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease.

Authors:  Alexander L Chin; Selamawit Negash; Roy Hamilton
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jul-Sep       Impact factor: 2.703

7.  Education, Occupational Complexity, and Incident Dementia: A COSMIC Collaborative Cohort Study.

Authors:  Jinshil Hyun; Charles B Hall; Mindy J Katz; Carol A Derby; Darren M Lipnicki; John D Crawford; Antonio Guaita; Roberta Vaccaro; Annalisa Davin; Ki Woong Kim; Ji Won Han; Jong Bin Bae; Susanne Röhr; Steffi Riedel-Heller; Mary Ganguli; Erin Jacobsen; Tiffany F Hughes; Henry Brodaty; Nicole A Kochan; Julian Trollor; Antonio Lobo; Javier Santabarbara; Raul Lopez-Anton; Perminder S Sachdev; Richard B Lipton
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

Review 8.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

9.  Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).

Authors:  Badri N Vardarajan; Kelley M Faber; Thomas D Bird; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Robert A Sweet; Rafael Lantigua; Martin Z Medrano; Ruth Ottman; Daniel J Schaid; Tatiana M Foroud; Richard Mayeux
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

Review 10.  Worldwide prevalence and incidence of dementia.

Authors:  L Fratiglioni; D De Ronchi; H Agüero-Torres
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.